Article

BVI purchases ophthalmic assets from Odyssey

Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions.

 

Waltham, MA-Beaver-Visitec International Inc. (BVI) has purchased the ophthalmic assets from Odyssey Medical Inc., which specializes in dry eye solutions. BVI is a portfolio company of RoundTable Healthcare Partners, an operating-oriented private equity firm focused on the healthcare industry.

“We are excited to bring Odyssey to our customers as a part of the Beaver-Visitec family,” said Tom Kapfer, chief executive officer of BVI. “We are committed to providing high-quality single-use products with the performance and precision clinicians expect. Odyssey is a perfect fit with our goal.”

"BVI and Odyssey both believe in offering the best products to our customers,” added Barbara Tatge, a former owner of Odyssey who will be joining BVI. “This shared value is what attracted us to BVI.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.